November/December 2014

 

In this Issue

Beyond IOP

Other factors in the development, progression, and management of Glaucoma.

Issue

Supplement

Insert

View the E-Dition

CHIEF MEDICAL EDITOR’S PAGE

Personalized Glaucoma Care

By Steven D. Vold, MD

THE LITERATURE

The Literature

By Dipika B. Joshi, MD, and Tak Yee Tania Tai, MD

INTERNATIONAL PERSPECTIVES

Glaucoma in the Kingdom of Saudi Arabia

This growing population requires more glaucoma subspecialists and tertiary care centers.

By Deepak P. Edward, MD; Ibrahim Al Jadaan, MD; and E. Randy Craven, MD

SURGICAL PEARLS

Will the Cost of Clinical Trials Quash Change in Glaucoma Treatment?

Financial burden compromises phase 3 trials and prolongs the approval of surgical devices.

By Alan L. Robin, MD

RESIDENTS AND FELLOWS

What I Sought and What I Found

By Deborah Kim, MD

COVER STORIES

Topical Glaucoma Treatment and the Cornea

Alternative strategies may benefit patients with a compromised ocular surface.

By Adam C. Reynolds, MD

Sidebar: Corneal Hysteresis

By Felipe A. Medeiros, MD, PhD

Vascular Considerations in Glaucoma Management

Evidence strongly suggests that ocular blood flow plays a role in glaucoma pathophysiology.

By Alon Harris, MS, PhD; Rehan Hussain, MD; Scott Wentz; and Brent Siesky, PhD

Neuroprotection in Glaucoma

Researchers continue to seek strategies and agents independent of IOP lowering that will protect neurons from apoptosis.

By Zakaria Bannur, MD, MSc(MEDICINE); Sushil Vasudevan, MBBS, MSurg(Ophth); Jonathan G. Crowston, FRCOphth, FRANZCO, PhD; and Ivan Goldberg, AM, MBBS, FRANZCO, FRACS

Genetics in Glaucoma Diagnosis and Management

Gene-based tests and therapies carry important implications for clinical practice.

By Inas F. Aboobakar, BS, and R. Rand Allingham, MD

Immunologic Considerations in Glaucoma Care

Innate and adaptive immune responses represent elusive but important components of the human glaucomatous process.

By Louis R. Pasquale, MD, and Meredith Gregory-ksander, PhD

Managing Systemic Disease in the Glaucoma Patient

Many systemic diseases may be correlated with glaucoma. Conversely, glaucoma treatments can affect a patient’s other systemic diseases.

By Jennifer Somers Weizer, MD

Current Approaches to Low-Tension Glaucoma

This challenging condition requires individualized care.

By Carla J. Siegfried, MD

PRACTICE POINTERS

Negotiating Language Barriers

Practitioners describe how they build trust through communication with patients who do not speak English.

By Rohit Varma, MD, MPH; Justin Schweitzer, OD; Darrell Wudunn, MD, PhD; and Walter O. Whitley, OD, MBA

THERAPEUTICS UPDATE

Discovering the Root Cause of Dry Eye Symptoms

In-office technologies aid clinicians’ diagnosis and treatment of DED.

By Howard Barnebey, MD

INSIDE EYETUBE.NET

Tube Coverage: Another Approach

By Jonathan S. Myers, MD

Robert M. Feldman, MD

Dr. Feldman describes the challenges facing a department chair and busy clinician delivering glaucoma care.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.